Henkel

Last updated January 31, 2026

141

Innovation Areas

3,300

Inventors

Collaborations

Halide-free chitosan polymer networks: HenkelRecent Research Landscape

Inconsistent particle deposition in pulmonary delivery leads to poor therapeutic efficacy and wasted active ingredients. These innovations engineer specific propellant-solvent ratios to ensure uniform droplet size and stable aerosolization.

What technical problems is Henkel addressing in Halide-free chitosan polymer networks?

Visible white residue formation

(1)evidences

Inconsistent particle distribution and poor bioavailability in aerosolized delivery systems. Optimizing deposition increases therapeutic efficacy and reduces dosage requirements.